Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00849615
What this trial is testing

Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Gastric CancerAdenocarcinoma of the Esophagogastric Junction
Krankenhaus Nordwest 252
Testing effectiveness (Phase 2)Ended earlyNCT01579578
What this trial is testing

Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer

Who this might be right for
Metastatic, Gastric or Gastro-oesophageal Junction, Cancer
AstraZeneca 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04028167
What this trial is testing

Induction FLOT With CROSS CRT for Esophageal Cancer

Who this might be right for
Adenocarcinoma EsophagusAdenocarcinoma of the Gastroesophageal Junction
University of Colorado, Denver 40
Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Not applicableLooking for participantsNCT06158919
What this trial is testing

PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer

Who this might be right for
Gastric Cancer/Adenocarcinoma of Esophagogastric Junction
Fudan University 58
Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Testing effectiveness (Phase 2)Study completedNCT00374985
What this trial is testing

Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Johannes Gutenberg University Mainz 25
Testing effectiveness (Phase 2)Looking for participantsNCT07529808
What this trial is testing

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more
BigHat Biosciences, Inc. 164
Early research (Phase 1)Not Yet RecruitingNCT07252661
What this trial is testing

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more
AccSalus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621562
What this trial is testing

Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Juction CancerProficient Mismatch Repair
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT01262482
What this trial is testing

Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

Who this might be right for
Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)
Grupo Espanol Multidisciplinario del Cancer Digestivo 41
Not applicableUnknownNCT03302403
What this trial is testing

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Who this might be right for
B Cell LymphomaB Cell LeukemiaMyeloma+3 more
Kang YU 18
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT00525785
What this trial is testing

Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)

Who this might be right for
Stomach CancerGastric Cancer
M.D. Anderson Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT02795988
What this trial is testing

IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

Who this might be right for
Gastrointestinal NeoplasmsAdenocarcinoma
Imugene Limited 64
Testing effectiveness (Phase 2)Ended earlyNCT01457846
What this trial is testing

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Who this might be right for
Gastro-oesophageal Junction CancerGastric Cancer
AstraZeneca 960
Testing effectiveness (Phase 2)UnknownNCT05705635
What this trial is testing

Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of Gastroesophageal Junction
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT01333033
What this trial is testing

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 257
Testing effectiveness (Phase 2)Ended earlyNCT04363801
What this trial is testing

DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastroEsophageal Cancer
Leap Therapeutics, Inc. 247
Testing effectiveness (Phase 2)Study completedNCT00074009
What this trial is testing

Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Memorial Sloan Kettering Cancer Center
Next Page